What Causes Baby Heart Rate to Increase in the Womb
Fetal Tachycardia
i. What every clinician should know
Clinical features and incidence
Fetal tachycardia is divers every bit a heart rate greater than 160-180 beats per infinitesimal (bpm). This rapid rate may have a regular or irregular rhythm which may be intermittent or sustained. A sustained fetal tachyarrhythmia is uncommon, affecting fewer than 1% of all pregnancies.
Risk factors
There are a number of maternal conditions that increase the likelihood of tachycardia in the fetus. Hyperthyroidism secondary to thyroid stimulating antibodies, fever associated with systemic infections and substance corruption may result in an increment in the fetal heart rate above the normal range. Beta-agonists used in the treatment of asthma or for tocolysis tin can cantankerous the placenta and cause a fetal tachycardia. Fetal tachycardia also can exist the presenting sign of intrauterine infection and chorioamnionitis and associated with metabolic derangements in the fetus.
In addition to extrinsic factors, congenital centre affliction predisposes the fetus to the development of a tachyarrhythmia. Ectopic beats, even in the presence of a normal fetal middle, increment the probability of a fetus developing a sustained tachyarrhythmia.
2. Diagnosis and differential diagnosis
A. Establishing the diagnosis
The diagnosis of fetal tachycardia is usually made during office auscultation or at the time of an ultrasound scan. A fetal heart rate of over 160-180 bpm requires a thorough maternal history and examination, screening for potential precipitating factors. A history of leakage of fluid per vagina or uterine tenderness on palpation may indicate intrauterine infection. Fetal tachycardia in labor may point the presence of chorioamnionitis or the evolution of metabolic acidemia. Thyroid role tests, CBC with differential, samples for culture and sensitivity, and a urine toxicology screen may exist indicated.
A comprehensive fetal anatomic survey with particular attention to the screening views of the heart should be performed. A significant tachyarrhythmia tin lead to the development of hydrops and so an assessment for pericardial, pleural, ascitic and subcutaneous fluid is indicated. (Figure 1) Amniotic fluid volume should also be quantified, as oligohydramnios may bespeak membrane rupture while polyhydramnios is often associated with congestive heart failure secondary to a sustained tachyarrhythmia.
Effigy i.
Abnormal fluid collection in two body cavities, the fetal breast and abdomen (arrows), consistent with diagnosis of fetal hydrops.
A detailed fetal echocardiogram is likewise warranted to firmly establish the rate and rhythm, confirm normal cardiac anatomy and assess any hemodynamic consequences related to the tachycardia. In addition to standard ii-dimensional imaging and color flow mapping, K-mode and pulsed Doppler are disquisitional for the label of a fetal arrhythmia.
B. Differential diagnosis
While the diagnosis of a fetal tachycardia is simple, establishing the nature of the tachycardia often requires further evaluation and consultation with an practiced in fetal echocardiography such as a maternal-fetal medicine specialist, radiologist or pediatric cardiologist. Fetal sinus tachycardia is almost commonly seen in cases related to maternal atmospheric condition, such as Graves' disease or infection, or secondary to drug apply. The fetal center charge per unit is normally less than 200 bpm and tends to resolve once the precipitating status is corrected or exposure eliminated. In this type of tachycardia, there is ane-to-1, atrial-to-ventricular conduction with origin from the sinus node.
In contrast, extra beats are triggered by ectopic foci in the wall of the heart and outcome in an irregular rhythm of the fetal heart rate. Premature atrial contractions (PACs) and premature ventricular contractions (PVCs) affect 1-2% of all pregnancies and are responsible for over 90% of arrhythmias detected in utero, with atrial extrasystoles being most common. (Figure 2 and Effigy 3) Ectopic beats occur earlier than expected and may be followed past a ventricular contraction. The subsequent atrial contraction tends to be delayed due to a compensatory interruption.
Figure 2.
Thou-fashion echocardiogram exhibiting a premature atrial contraction.
Figure 3.
Pulsed Doppler demonstrating a premature atrial wrinkle (pointer). The normally biphasic atrioventricular waveform appears uniphasic with fusion of the eastward wave (passive ventricular filling) with the a moving ridge (atrial wrinkle).
In some cases, the ectopic beats can couple to sinus beats leading to atrial bigeminy or trigeminy. (Figure iv and Figure 5) These extra beats are believed to be secondary to immaturity of the fetal conduction organization and tend to resolve spontaneously with advancing gestational age. As a result, in the absence of underlying cardiac malformations or tumors stimulating these foci, extrasystoles are considered beneficial, well tolerated and generally do not require whatever in utero treatment. (Effigy half dozen and Figure 7) However, in ii-three% of cases, progression to a clinically significant arrhythmia occurs.
Figure iv.
M-fashion echocardiogram showing the rhythm associated with atrial bigeminy. At that place are ii atrial contractions for each ventricular contraction.
Figure five.
Pulsed Doppler across the mitral valve displaying the characteristic pattern of atrial bigeminy, 1 sinus crush for each ectopic beat. Initial presentation is often a low fetal heart rate detected during office auscultation.
Figure 6.
A regurgitant (pointer) dysplastic tricuspid valve has been associated with lethal tachyarrhythmias in fetuses with Ebstein anomaly.
Figure 7.
Cardiac tumors (arrows) in the left ventricle and interatrial septum predisposing the fetus to extrasystoles.
Tachyarrhythmias, such as supraventricular tachycardia, atrial flutter and atrial fibrillation, are ordinarily intrinsic to the fetus with the potential to adversely bear upon fetal well-being. Overall, these serious tachyarrhythmias comprise less than 10% of arrhythmias detected prenatally. The virtually common tachyarrhythmia is supraventricular tachycardia (SVT), representing up to 5% of all fetal arrhythmias. Both pulsed Doppler and 1000-manner echocardiography tin can be used to recognize SVT which tends to accept an atrial charge per unit of 220 to 240 bpm with 1-to-1 atrioventricular conduction. (Figure 8)
Figure 8.
K-manner echocardiography revealing a supraventricular tachycardia with 1:one atrial-to-ventricular conduction.
This rapid atrial reactivation occurs as a outcome of a fast-conducting, accessory pathway that permits reentry of electrical activity from the ventricle to atrium. SVT may be sustained or intermittent in response to frequent atrial extrasystoles. Congenital heart illness is constitute In up to 5% of SVT cases and hydrops fetalis in 30-50%.
While SVT is the nigh likely intrinsic cause of fetal tachycardia, atrial flutter and atrial fibrillation are other possibilities. The distinction oftentimes is made using One thousand-manner echocardiography to demonstrate the characteristic saw-tooth appearance of atrial contractions in cases of palpitate or the irregularly irregular appearance of atrial activity in fibrillation. In SVT the atrial and ventricular rates are the same; in atrial palpitate and fibrillation, these rates are different depending on the degree of atrioventricular block.
There tends to exist no human relationship betwixt atrial and ventricular activity in atrial fibrillation due to blocked conduction, and in atrial flutter at that place can be ii-1, three-1, or even 4-1 conduction with atrial rates over 300-400 bpm. Atrial flutter and fibrillation are relatively uncommon, and ventricular tachyarrhythmias exceedingly rare when compared to fetal SVT.
3. Management
Antepartum
Extrinsic causes of fetal tachycardia should exist identified and treated appropriately. Sinus tachycardia secondary to maternal hyperthyroidism can be managed with antithyroid medications such every bit methimazole. Antibiotics are necessary for maternal systemic infections and acetaminophen can be used brusk-term to reduce maternal fever and afterwards to normalize the fetal heart rate. Whatever drugs that may precipitate a sinus tachycardia should also be discontinued. Unfortunately, intrauterine infection with chorioamnionitis is an indication for evacuation of the delivery, which may result in a termination of pregnancy or preterm delivery rather than a term birth.
Although PACs and PVCs tin can trigger the onset of SVT, they are benign without pregnant sequelae in the majority of cases. A fetal echocardiogram should be obtained when these extra beats are detected to exclude associated centre anomalies and to ostend the diagnosis. Smoking, alcohol, and ingestion of caffeine-containing products should exist eliminated. Series surveillance with office auscultation or ultrasound examination every ane-2 weeks is recommended in these cases until no further extrasystoles are detected. If a fetal tachycardia is discovered on follow-upward assessments, echo fetal echocardiography and consultation with pediatric cardiology is advised.
Different extrasystoles, fetal tachyarrhythmias may require intervention depending on gestational age, coexisting congenital heart disease and hazard for hemodynamic compromise. This gamble depends on the fetal heart rate, the type of tachyarrhythmia, and whether it is intermittent or sustained. The presence of hydrops indicates that the tachyarrhythmia is non well tolerated and that medical therapy or commitment should be considered based on gestational historic period. When major heart defects are as well nowadays and the prognosis is poor, expectant management may exist desired by the patient and her family
In the absence of hemodynamic compromise and hydrops, expectant management may also exist reasonable for cases of intermittent SVT. For SVT that occurs less than l% of the fourth dimension over a 24-hr period of observation, spontaneous resolution is common over a period of days to weeks. Nevertheless, frequent reassessments are necessary to exclude conversion to a sustained SVT then many patients and practitioners elect to keep with medical therapy if remote from term. In utero conversion to normal sinus rhythm involves the administration of antiarrhythmic agents to the mother.
Digoxin is the near commonly used drug for fetal SVT, administered to the mother at a dose of 0.25 mg every 8 hours orally to achieve maternal plasma levels of 0.8-ii ng/ml. Despite the safety of digoxin, consultation with adult cardiology is recommended when prescribing antiarrhythmic agents to significant women. A thorough baseline cardiac evaluation including an electrocardiogram is warranted for comparison to subsequent testing after the initiation of medial therapy. This is even more important when proarrhythmic drugs such as flecanide or procainamide are used. Flecanide is oft used equally the second-line agent if digoxin fails to effect in cardioversion.
Even in the absence of achieving sinus rhythm, decreasing the fetal heart charge per unit below 200 bpm lowers the risk of hemodynamic compromise. In cases of hydrops, the transplacental transfer of digoxin is decreased so flecanide is oft used as first-line therapy. Sotalol is another usually used second-line agent in the handling of fetal tachyarrhythmias. Overall, the administration of antiarrhythmic drugs to the mother results in successful cardioversion in 80-90% of cases.
However, this is reduced to 65-75% in cases of hydrops and fifty-fifty when normal sinus rhythm is restored, it takes weeks for the hydrops to resolve. Similar treatment approaches are used for atrial flutter and fibrillation merely the goal is often just to control the rate every bit these tachyarrhythmias are much more difficult to convert to sinus rhythm.
Intrapartum
Regardless of whether the cause of the tachycardia is extrinsic or intrinsic to the fetus, persistent fetal tachycardia during the intrapartum period limits the power to monitor the fetal response to labor to ensure fetal well-existence. New-onset fetal tachycardia in labor may signal intrauterine infection or fetal acidemia, so prompt evaluation, judicious interventions and timely delivery is indicated.
Unresolved maternal conditions causing fetal sinus tachycardia or unsuccessfully treated fetal tachyarrhythmias will almost certainly require cesarean delivery unless nonintervention is planned due to a circumstantial cardiac malformation. A trial of labor with vaginal delivery tin be considered in cases with spontaneous or medically-induced conversion to normal sinus rhythm. Regardless of the planned mode of delivery, neonatologists and pediatric cardiologists experienced in the management of tachyarrhythmias should be available for the immediate evaluation of the newborn.
Postpartum
A normal mail service-operative class is expected for those requiring a cesarean delivery and normal postpartum course for those having a vaginal birth. Any antiarrhythmic agent administered to the mother can be discontinued. Bonding and breastfeeding may be delayed if the baby requires lengthy observation in the neonatal intensive care unit of measurement and prolonged hospitalization. Overall, a normal postpartum course is expected.
4. Complications
A. Complications as a consequence of the condition
The major risks of fetal tachycardia are hemodynamic compromise, development of hydrops and intrauterine fetal death. The best strategy to avert these complications is to place and treat maternal weather condition causing fetal sinus tachycardia and to deliver term pregnancies or medically manage preterm pregnancies with fetal tachyarrhythmias that take features associated with a poor prognosis. Fetal tachycardia due to intrauterine infection or fetal acidemia may be associated with adverse outcomes such as neonatal asphyxia, hypoxic-ischemic encephalopathy and cerebral palsy.
B. Complications every bit a consequence of management
Both maternal and fetal agin effects have been reported secondary to the administration of antiarrhythmic agents in pregnancy. While prolongation of the PR interval can catechumen the fetus with SVT into sinus rhythm, the same consequence can be detrimental to a good for you female parent. Proarrhythmic drugs tin can result in life-threatening arrhythmias in the mother and cases of sudden death in the fetus. Conscientious drug option in consultation with pediatric and adult cardiologists and close follow-up of both patients are required for optimal direction of fetal tachyarrhythmias requiring maternal medical therapy.
5. Prognosis and outcome
A. Maternal and fetal/neonatal outcomes
The outcome of pregnancies complicated by fetal tachycardia is related to the underlying cause of the arrhythmia. PACs and PVCs are benign and the prognosis is excellent. In cases where these extrasystoles consequence in SVT and in utero medical therapy is successful, a favorable issue is too expected. The majority of these infants are treated with antiarrhythmic agents for 12 months and about fourscore% will not require any intervention across that get-go year.
In those with a sustained tachyarrhythmia, antiarrhythmic drugs or ablation of accessory pathways in cases of SVT may exist required. In these cases, the prognosis remains practiced merely is more guarded if there is coexisting structural heart defects. Fetal tachycardia related to chorioamnionitis or metabolic acidemia as well tends to have a favorable outcome but may be associated with permanent neurologic injury related to the inciting condition.
B. Impact on long term health
In general, fetal tachyarrhythmias have no lasting impact on a woman's well-existence apart from an increased risk for cesarean commitment and its implications on futurity health. If a chronic condition such as Graves' disease or substance abuse precipitated a fetal tachycardia, advisable referral and handling is required to optimize long-term prognosis. Loss of a pregnancy from intrauterine infection or nativity of a preterm infant due to membrane rupture and chorioamnionitis may complicate a patient's physical and mental wellness. Neurological damage or complications of prematurity in survivors tin can too have psychological consequences on parental well-being. However, in the majority of cases of fetal tachycardia a favorable maternal outcome is predictable.
half dozen. What is the testify for specific management and handling recommendations
Cuneo, BF. "Treatment of fetal tachycardia". Eye Rhythm. vol. 5. 2008. pp. 1216-8. (Review of the treatment options for fetal tachycardia.)
Lopriore, Due east, Aziz, MI, Nagel, HT, Blom, NA, Rozendaal, 50. "Long-term neurodevelopmental outcome after fetal arrhythmia". Am J Obstet Gynecol. vol. 201. 2009. pp. 46.e1-v. (I of few studies looking at neurodevelopment outcomes of tachyarrhythmias.)
Kleinman, CS, Nehgme, RA. "Cardiac arrhythmias in the human fetus". Pediatr Cardiol. vol. 25. 2004. pp. 234-51. (Wonderful review past the "father" of fetal echocardiography, the late Charlie Kleinman.)
Matta, MJ, Cuneo, BF. "Doppler echocardiography for managing fetal cardiac arrhythmia". Clin Obstet Gynecol. vol. 53. 2010. pp. 899-914. (Reviews the diagnosis and treatment of fetal dysrhythmias.)
Rasiah, SV, Ewer, AK, Miller, P, Kilby, Medico. "Prenatal diagnosis, managment and outcome of fetal dysrhythmia: a tertiary fetal medicine middle feel over an eight-year menstruum". Fetal Diagn Ther. vol. 30. 2011. pp. 122-7. (Experience of a single referral center.)
Simpson, JM. "Fetal arrhythmias". Ultrasound Obstet Gynecol. vol. 27. 2006. pp. 599-606. (Some other proficient review of fetal dysrhythmias.)
van den Heuvel, F, Bink-Boelkens, MT, du Marchie Sarvaas, GJ, Berger, RM. "Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based arroyo?". Pacin Clin Electrophysiol. vol. 31. 2008. pp. S54-7. (Discussion of handling approach of fetal tachycardia.)
Copyright © 2017, 2013 Conclusion Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Source: https://www.cancertherapyadvisor.com/home/decision-support-in-medicine/obstetrics-and-gynecology/fetal-tachycardia/
0 Response to "What Causes Baby Heart Rate to Increase in the Womb"
Post a Comment